Dr. Donovan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Union Square East
Mount Sinai Downtown Union Square, 2EF
New York, NY 10003Phone+1 212-420-4412Fax+1 212-420-2224
Summary
- Dr. Daniel Donovan is an endocrinologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, Mount Sinai Hospital, Mount Sinai Brooklyn, Mount Sinai West, Mount Sinai Beth Israel, Mount Sinai Queens, and Mount Sinai St. Luke's. He received his medical degree from Icahn School of Medicine at Mount Sinai and has been in practice 31 years. He also speaks multiple languages, including Spanish. He specializes in diabetes, lipid metabolism, pituitary disorders & neuroendocrinology, and thyroid and is experienced in neuroendocrinology.
Education & Training
- Columbia University Mailman School of Public HealthMS, Biostatistics/ Patient Oriented Research, POR Scholar, 2009 - 2011
- Brigham and Women's HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1990 - 1993
- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1986 - 1989
- Icahn School of Medicine at Mount SinaiClass of 1986
Certifications & Licensure
- NY State Medical License 1988 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
- American Board of Obesity Medicine Obesity Medicine
Awards, Honors, & Recognition
- Fellow (FACE) American Association of Clinical Endocrinology
Publications & Presentations
PubMed
- 10 citationsIs Pes Cavus Alignment Associated With Lisfranc Injuries of the FootJeremy D. Podolnick, Daniel S. Donovan, Nicholas Debellis, Alejandro Pino
Clinical Orthopaedics and Related Research. 2017-05-01 - 18 citationsEffects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E.John S. Millar, Michael E. Lassman, Tiffany Thomas, Rajasekhar Ramakrishnan, Patricia Jumes
Journal of Lipid Research. 2017-03-17 - 6 citationsAnacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects.John S Millar, Gissette Reyes-Soffer, Patricia Jumes, Richard L Dunbar, Emil M deGoma
The Journal of Clinical Investigation. 2016-04-01
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: